Scientific and Medical Equipment House Future Growth
Future criteria checks 1/6
Scientific and Medical Equipment House is forecast to grow revenue at 11.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 14.8% |
| Revenue growth rate | 11.6% |
| Future return on equity | 12.9% |
| Analyst coverage | Low |
| Last updated | 27 Mar 2024 |
Recent future growth updates
No updates
Recent updates
We Think That There Are Issues Underlying Scientific and Medical Equipment House's (TADAWUL:4014) Earnings
Apr 10
Potential Upside For Scientific and Medical Equipment House Company (TADAWUL:4014) Not Without Risk
Mar 21Scientific and Medical Equipment House Company (TADAWUL:4014) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Aug 14Scientific and Medical Equipment House's (TADAWUL:4014) Shareholders May Want To Dig Deeper Than Statutory Profit
Jun 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,153 | N/A | N/A | 50 | 1 |
| 12/31/2025 | 1,077 | N/A | N/A | 38 | 1 |
| 12/31/2024 | 978 | N/A | N/A | -19 | 1 |
| 12/31/2023 | 799 | 40 | -155 | -141 | N/A |
| 9/30/2023 | 756 | 1 | -69 | -48 | N/A |
| 6/30/2023 | 731 | -8 | 104 | 131 | N/A |
| 3/31/2023 | 716 | 8 | 122 | 146 | N/A |
| 12/31/2022 | 714 | 18 | 129 | 147 | N/A |
| 9/30/2022 | 730 | 60 | 6 | 21 | N/A |
| 6/30/2022 | 721 | 69 | -99 | -90 | N/A |
| 3/31/2022 | 710 | 75 | -125 | -117 | N/A |
| 12/31/2021 | 699 | 78 | -79 | -72 | N/A |
| 9/30/2021 | 649 | 76 | 34 | 42 | N/A |
| 6/30/2021 | 627 | 76 | 129 | 141 | N/A |
| 3/31/2021 | 615 | 73 | 124 | 142 | N/A |
| 12/31/2020 | 617 | 75 | 94 | 117 | N/A |
| 12/31/2019 | 597 | 71 | 152 | 163 | N/A |
| 12/31/2018 | 584 | 68 | -112 | -109 | N/A |
| 12/31/2017 | 556 | 49 | 75 | 78 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4014's forecast earnings growth is above the savings rate (14.3%).
Earnings vs Market: Insufficient data to determine if 4014's earnings are forecast to grow faster than the SA market
High Growth Earnings: Insufficient data to determine if 4014's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4014's revenue (11.6% per year) is forecast to grow faster than the SA market (-0.3% per year).
High Growth Revenue: 4014's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4014's Return on Equity is forecast to be low in 3 years time (12.9%).